Nephrology News

Sunitinib Dose Escalation May Benefit mRCC Patients

Added progression-free survival and prolonged overall survival possible, according to investigators.

By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/

Request Information

Invalid Input
Invalid Input
Invalid Input
Invalid Input